Dr James Garner is Chief Executive Officer and Managing Director of Percheron Therapeutics. Over a 20+ year career, including senior roles with Biogen, Takeda, and Sanofi, James has help to bring over a dozen new medicines forward to patients. Prior to joining Percheron, he was CEO of Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused biotech. James. is an MD by training. He completed an MBA at the University of Queensland, Australia, and spent several years working as a consultant with Bain & Company before entering industry.